---
title: "Entrada Therapeutics director, 10% owner Kush Parmar disposes of $807,529 in common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294740785.md"
description: "Kush Parmar, a director and 10% owner of Entrada Therapeutics, sold $807,529 worth of common shares on July 30-31. The transaction involved selling 116,474 shares at weighted average prices between $6.85 and $6.93. This sale reduced 5AM Ventures V’s stake to 2,846,592 shares, while 5AM Opportunities I retained 1,093,313 shares."
datetime: "2026-08-03T21:27:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294740785.md)
  - [en](https://longbridge.com/en/news/294740785.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294740785.md)
generator: "portal-rs"
---

# Entrada Therapeutics director, 10% owner Kush Parmar disposes of $807,529 in common shares

-   Entrada Therapeutics director Kush Parmar reported sales of 116,474 shares on July 30-31, cutting 5AM Ventures V’s stake to 2,846,592 shares. \* The July 30 sale covered 114,756 shares at a weighted average price of $6.93. \* The July 31 sale covered 1,718 shares at $6.85. \* 5AM Opportunities I held 1,093,313 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001664281-26-000002), on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [TRDA.US](https://longbridge.com/en/quote/TRDA.US.md)

## Related News & Research

- [Insider Selling: Entrada Therapeutics (NASDAQ:TRDA) Major Shareholder Sells $26,168.33 in Stock](https://longbridge.com/en/news/297569145.md)
- [Insider Selling: Entrada Therapeutics (NASDAQ:TRDA) Major Shareholder Sells 14,569 Shares of Stock](https://longbridge.com/en/news/297116833.md)
- [Insider Selling: Riskified (NYSE:RSKD) Director Sells $22,590.81 in Stock](https://longbridge.com/en/news/297901364.md)
- [Sea’s CCO and GC Wang Yanjun disposes of USD 287,194.74 in common shares](https://longbridge.com/en/news/297766468.md)
- [Etsy Executive Chair Josh Silverman disposes of common shares worth $1,112,922.19](https://longbridge.com/en/news/297964662.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**